01.01.2002 | Original Article
HER-2/neu-derived peptide 884–899 is expressed by human breast, colorectal and pancreatic adenocarcinomas and is recognized by in-vitro-induced specific CD4+ T cell clones
Erschienen in: Cancer Immunology, Immunotherapy | Ausgabe 11/2002
Einloggen, um Zugang zu erhalten